臨床試驗

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

NCT：NCT06608823 · RECRUITING

NCT IDNCT06608823

狀態RECRUITING

開始日期2025-06-18

SponsorJenaValve Technology, Inc. (INDUSTRY)

First posted2024-09-23

Last updated2026-09-17

簡要摘要

To demonstrate non-inferiority of the Trilogy Transcatheter Heart Valve (THV) System compared with surgical aortic valve replacement (SAVR) for treatment of subjects with clinically significant native aortic regurgitation (AR)

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。